Epidemiology of infective endocarditis: novel aspects in the twenty-first century

References

• de Sa DDC, Tleyjeh IM, and Anavekar NS, et al. Epidemiological trends of infective endocarditis: a population-based study in Olmsted County, Minnesota. In: Mayo Clinic Proceedings USA. Elsevier; 2010. p. 422–426.
   Google Scholar
• Alkhouli M, Alqahtani F, Alhajji M, et al.Clinical and economic burden of hospitalizations for infective endocarditis in the United States.Mayo Clin Proc.2020;95(5):858–866;Internet].;():. Available from
   PubMed Web of Science ®Google Scholar
• Wilson W, Taubert KA, and Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association. Circulation. 2007;116(15):1736–1754 .
   PubMed Web of Science ®Google Scholar
• Habib G, Lancellotti P, Antunes MJ, et al. 2015. ESC GUIDELINES 2015 ESC guidelines for the management of infective endocarditis the task force for the management of infective endocarditis of the European Society Of Cardiology (ESC) Endorsed by: european Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Available from: https://academic.oup.com/eurheartj/article/36/44/3075/2293384
   Google Scholar
• NICE. Prophylaxis against infective endocarditis Antimicrobial prophylaxis against infective endocarditis in adults and children. National Institute for Health and Clinical Excellence. Natl Inst Clin Excell Guidel 64 [Internet]. 2008;(March):1–107. Available from: papers3://publication/uuid/42FCFEA6-9616-44E2-84A0-21074528BE46
   Google Scholar
• DeSimone DC, Tleyjeh IM, Correa De Sa DD, et al. Incidence of infective endocarditis due to viridans group streptococci before and after the 2007 american heart association’s prevention guidelines: an extended evaluation of the olmsted county, minnesota, population and nationwide inpatient sample. Mayo Clin Proc. 2015 Jul 1 90(7):874–881.
   PubMed Web of Science ®Google Scholar
• Pant S, Patel NJ, Deshmukh A, et al. Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011. J Am Coll Cardiol. 2015;65(19):2070–2076.
   PubMed Web of Science ®Google Scholar
• Alkhouli M, Alqahtani F, Alhajji M, et al. Clinical and economic burden of hospitalizations for infective endocarditis in the United States. In: Mayo Clinic Proceedings. Elsevier; 2020. p. 858–866.
   Google Scholar
• Toyoda N, Chikwe J, Itagaki S, et al. Trends in infective endocarditis in California and New York State, 1998-2013. Jama. 2017;317(16):1652–1660.
   PubMed Web of Science ®Google Scholar
• Bikdeli B, Wang Y, Kim N, et al. Trends in hospitalization rates and outcomes of endocarditis among medicare beneficiaries. J Am Coll Cardiol. 2013;62(23):2217–2226.
   PubMed Web of Science ®Google Scholar
• Yang X, Chen H, and Zhang D, et al. Global magnitude and temporal trend of infective endocarditis, 1990–2019: results from the Global Burden of Disease Study. Eur J Prev Cardiol. 2021. https://doi.org/10.1093/eurjpc/zwab184
   Google Scholar
• Naderi HR, Sheybani F, Erfani SS. Errors in diagnosis of infective endocarditis. Epidemiol Infect. 2018;146(3):394–400.
   PubMed Web of Science ®Google Scholar
• Danchin N, Duval X, Leport C. Prophylaxis of infective endocarditis: french recommendations 2002. Heart. 2005;91(6):715–718.
   PubMed Web of Science ®Google Scholar
• Wilson WR, Gewitz M, and Lockhart PB, et al. prevention of viridans group streptococcal infective endocarditis: a scientific statement from the American Heart Association. Circulation. 2021;143:1–16.
   Web of Science ®Google Scholar
• Thornhill MH, Dayer MJ, Prendergast B, et al. Incidence and nature of adverse reactions to antibiotics used as endocarditis prophylaxis. J Antimicrob Chemother. 2015;70(8):2382–2388.
   PubMed Web of Science ®Google Scholar
• Watkins DA, Johnson CO, Colquhoun SM, et al. Global, regional, and national burden of rheumatic heart disease, 1990–2015. N Engl J Med. 2017;377(8):713–722.
   PubMed Web of Science ®Google Scholar
• Nunes MCP, Gelape CL, Ferrari TCA. Profile of infective endocarditis at a tertiary care center in Brazil during a seven-year period: prognostic factors and in-hospital outcome. Int J Infect Dis. 2010;14(5):e394–8.
   PubMed Web of Science ®Google Scholar
• Longo-Mbenza B, Bayekula M, Ngiyulu R, et al. Survey of rheumatic heart disease in school children of Kinshasa town. Int J Cardiol. 1998;63(3):287–294.
   PubMed Web of Science ®Google Scholar
• Remenyi B, Carapetis J, Wyber R, et al. Position statement of the World Heart Federation on the prevention and control of rheumatic heart disease. Nat Rev Cardiol. 2013;10(5):284.
   PubMed Web of Science ®Google Scholar
• Kumar RK, Antunes MJ, Beaton A, et al. Contemporary diagnosis and management of rheumatic heart disease: implications for closing the gap: a scientific statement from the American heart association. Circulation. 2020;142(20):e337–57.
   PubMed Web of Science ®Google Scholar
• Kaye D. Changing pattern of infective endocarditis. Am J Med. 1985;78(6):157–162.
   PubMed Web of Science ®Google Scholar
• Cherubin CE, Neu HC. Infective endocarditis at the presbyterian hospital in New York City from 1938–1967. Am J Med. 1971;51(1):83–96.
   PubMed Web of Science ®Google Scholar
• Thornhill MH, Jones S, and Prendergast B, et al. Quantifying infective endocarditis risk in patients with predisposing cardiac conditions. [cited 2017 Nov 17]. Available from: http://content.digital.nhs.uk
   Google Scholar
• Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association task force and the European Society of Cardiology Com. Europace. 2006;8(9):746–837.
   PubMed Web of Science ®Google Scholar
• Torbica A, Banks H, Valzania C, et al. Investigating regional variation of cardiac implantable electrical device implant rates in European healthcare systems: what drives differences? Health Econ. 2017;26:30–45.
   PubMed Web of Science ®Google Scholar
• Voigt A, Shalaby A, Saba S. Continued rise in rates of cardiovascular implantable electronic device infections in the United States: temporal trends and causative insights. Pacing Clin Electrophysiol. 2010;33(4):414–419.
   PubMed Web of Science ®Google Scholar
• Jensen AD, Bundgaard H, Butt JH, et al. Temporal changes in the incidence of infective endocarditis in Denmark 1997–2017: a nationwide study. Int J Cardiol. 2021;326:145–152.
   PubMed Web of Science ®Google Scholar
• Greenspon AJ, Patel JD, Lau E, et al. 16-Year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States: 1993 to 2008. J Am Coll Cardiol. 2011;58(10):1001–1006.
   PubMed Web of Science ®Google Scholar
• Le KY, Sohail MR, Friedman PA, et al. Clinical predictors of cardiovascular implantable electronic device-related infective endocarditis. Pacing Clin Electrophysiol. 2011;34(4):450–459.
   PubMed Web of Science ®Google Scholar
• Sohail MR, Henrikson CA, Braid-Forbes MJ, et al. Mortality and cost associated with cardiovascular implantable electronic device infections. Arch Intern Med. 2011;171(20):1821–1828.
   PubMedGoogle Scholar
• Morita Y, Haruna T, Haruna Y, et al. Thirty-Day Readmission After Infective Endocarditis: analysis From a Nationwide Readmission Database. J Am Heart Assoc. 2019;8(9). https://doi.org/10.1161/JAHA.118.011598.
   Google Scholar
• Pasupula DK, Bhat AG, and Siddappa Malleshappa SK, et al. Trends and predictors of 30-day readmission among patients hospitalized with infective endocarditis in the United States. Cureus. 2019;11(6):e4962 .
   PubMed Web of Science ®Google Scholar
• Han H-C, Hawkins NM, Pearman CM, et al. Epidemiology of cardiac implantable electronic device infections: incidence and risk factors. EP Eur. 2021;23(Supplement_4):iv3–10.
   PubMed Web of Science ®Google Scholar
• Asundi A, Stanislawski M, Mehta P, et al. Real-world effectiveness of infection prevention interventions for reducing procedure-related cardiac device infections: insights from the veterans affairs clinical assessment reporting and tracking program. Infect Control Hosp Epidemiol. 2019;40(8):855–862.
   PubMed Web of Science ®Google Scholar
• Kewcharoen J, Kanitsoraphan C, Thangjui S, et al. Postimplantation pocket hematoma increases risk of cardiac implantable electronic device infection: a meta‐analysis. J Arrhythmia. 2021;37(3):635–644.
   PubMed Web of Science ®Google Scholar
• Martinelli M, Nishioka SAD, Varejão T, et al. Efficacy of antibiotic prophylaxis before the implantation of pacemakers and cardioverter-defibrillators: results of a large, prospective, randomized, double-blinded, placebo-controlled trial. Circ Arrhythmia Electrophysiol. 2009;2(1):29–34.
   PubMed Web of Science ®Google Scholar
• Tarakji KG, Mittal S, Kennergren C, et al. Antibacterial envelope to prevent cardiac implantable device infection. N Engl J Med. 2019;380(20):1895–1905.
   PubMed Web of Science ®Google Scholar
• Rennert-May E, Raj SR, Leal J, et al. Economic evaluation of an absorbable antibiotic envelope for prevention of cardiac implantable electronic device infection. EP Eur. 2021;23(5):767–774.
   PubMed Web of Science ®Google Scholar
• Krahn AD, Longtin Y, Philippon F, et al. Prevention of Arrhythmia Device Infection Trial: the PADIT Trial. J Am Coll Cardiol. 2018;72(24):3098–3109.
   PubMed Web of Science ®Google Scholar
• Birnie DH, Wang J, Alings M, et al. Risk Factors for Infections Involving Cardiac Implanted Electronic Devices.JACC. 2019 [2020 January 07];74(23):2845–2854.
   Web of Science ®Google Scholar
• Boriani G, Kennergren C, Tarakji KG, et al. Cost-effectiveness analyses of an absorbable antibacterial envelope for use in patients at increased risk of cardiac implantable electronic device infection in Germany, Italy, and England. Value Heal. 2021;24(7):930–938.
   PubMed Web of Science ®Google Scholar
• El-Chami MF, Bonner M, Holbrook R, et al. Leadless pacemakers reduce risk of device-related infection: review of the potential mechanisms. Hear Rhythm. 2020 Aug 1 17(8):1393–1397.
   PubMed Web of Science ®Google Scholar
• Zhou S, Egorova N, Moskowitz G, et al. Trends in MitraClip, mitral valve repair, and mitral valve replacement from 2000 to 2016. J Thorac Cardiovasc Surg. 2020. Internet]. Available from. DOIhttps://doi.org/10.1016/j.jtcvs.2019.12.097.
   Google Scholar
• Svensson LG, Ph D, and Tuzcu EM , et al. Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients. N Engl J Med. 2011;364:2187–2198.
   PubMed Web of Science ®Google Scholar
• Reardon MJ, Van Mieghem NM, Popma JJ, et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2017;376(14):1321–1331.
   PubMed Web of Science ®Google Scholar
• Østergaard L, Valeur N, Ihlemann N, et al. Incidence and factors associated with infective endocarditis in patients undergoing left-sided heart valve replacement. Eur Heart J. 2018;39(28):2668–2675.
   PubMed Web of Science ®Google Scholar
• Erichsen P, Gislason GH, Bruun NE. The increasing incidence of infective endocarditis in Denmark, 1994–2011. Eur J Intern Med. 2016 Nov 1; 35:95–99
   PubMed Web of Science ®Google Scholar
• Amat-Santos IJ, Messika-Zeitoun D, Eltchaninoff H, et al. Infective endocarditis after transcatheter aortic valve implantation results from a large multicenter registry. Circulation. 2015;131(18):1566–1574.
   PubMed Web of Science ®Google Scholar
• Habib G, Hoen B, Tornos P, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer. Eur Heart J. 2009;30(19):2369–2413.
   PubMed Web of Science ®Google Scholar
• Cecchi E, Parrini I, Chinaglia A, et al. New diagnostic criteria for infective endocarditis: a study of sensitivity and specificity. Eur Heart J. 1997;18(7):1149–1156.
   PubMed Web of Science ®Google Scholar
• Castillo Almeida NE, Gurram P, Esquer Garrigos Z, et al.Diagnostic imaging in infective endocarditis: a contemporary perspective.Expert Rev Anti Infect Ther.2020;18(9):911–925;Internet].;():. Available from
   PubMed Web of Science ®Google Scholar
• Abdelghani M, Nassif M, Blom NA, et al. Infective endocarditis after melody valve implantation in the pulmonary position: a systematic review. J Am Heart Assoc. 2018;7(13):e008163.
   PubMed Web of Science ®Google Scholar
• McElhinney DB, Zhang Y, Aboulhosn JA, et al. Multicenter study of endocarditis after transcatheter pulmonary valve replacement. J Am Coll Cardiol. 2021;78(6):575–589.
   PubMed Web of Science ®Google Scholar
• Malekzadeh-Milani S, Ladouceur M, Patel M, et al. Incidence and predictors of Melody® valve endocarditis: a prospective study. Arch Cardiovasc Dis. 2015;108(2):97–106.
   PubMed Web of Science ®Google Scholar
• V SAS, McAllister DA, Gallacher P, et al. Incidence, microbiology, and outcomes in patients hospitalized with infective endocarditis. Circulation. 2020;141(25):2067–2077.
   PubMed Web of Science ®Google Scholar
• Fernández-Hidalgo N, Larrosa MN, Fernandez-Galera R, et al. Secular trends in the epidemiology and clinical characteristics of Enterococcus faecalis infective endocarditis at a referral center (2007–2018). Eur J Clin Microbiol Infect Dis. 2021;40(6):1137–1148.
   PubMed Web of Science ®Google Scholar
• Regueiro A, Linke A, Latib A, et al. Association between transcatheter aortic valve replacement and subsequent infective endocarditis and in-hospital death. Jama. 2016;316(10):1083–1092.
   PubMed Web of Science ®Google Scholar
• Tortoli E, Rindi L, Garcia MJ, et al. Proposal to elevate the genetic variant MAC-A included in the Mycobacterium avium complex, to species rank as Mycobacterium chimaera sp. nov. Int J Syst Evol Microbiol. 2004;54(4):1277–1285.
   PubMed Web of Science ®Google Scholar
• Achermann Y, Rössle M, Hoffmann M, et al. Prosthetic valve endocarditis and bloodstream infection due to Mycobacterium chimaera. J Clin Microbiol. 2013;51(6):1769–1773.
   PubMed Web of Science ®Google Scholar
• Asadi T, Mullin K, Roselli E, et al. Disseminated Mycobacterium chimaera infection associated with heater–cooler units after aortic valve surgery without endocarditis. J Thorac Cardiovasc Surg. 2018;155(6):2369–2374.
   PubMed Web of Science ®Google Scholar
• Administration F and D. Nontuberculous mycobacterium (NTM) infections associated with heater-cooler devices (HCD) during cardiothoracic surgery. In: 2016 Meeting Materials of the Circulatory System Devices Panel, USA. [cited 2018 Mar 29] https://www.fdagov/AdvisoryCommittees/CommitteesMeeting-Materials/MedicalDevices/MedicalDevicesAdvisoryCommittee/CirculatorySystemDevicesPanel/ucm485091htm. 2016.
   Google Scholar
• Sax H, Bloemberg G, Hasse B, et al. Prolonged outbreak of Mycobacterium chimaera infection after open-chest heart surgery. Clin Infect Dis. 2015;61(1):67–75.
   PubMed Web of Science ®Google Scholar
• Hasse B, Hannan MM, Keller PM, et al. International society of cardiovascular infectious diseases guidelines for the diagnosis, treatment and prevention of disseminated Mycobacterium chimaera infection following cardiac surgery with cardiopulmonary bypass. J Hosp Infect. 2020;104(2):214–235.
   PubMed Web of Science ®Google Scholar
• Kaluza M, Färber G, May B, et al. Heater–Cooler Devices and Risk of Contamination during Cardiac Surgery. Thorac Cardiovasc Surg. 2021;69(8):703–709.
   PubMed Web of Science ®Google Scholar
• Fleischauer AT, Ruhl L, Rhea S, et al. Hospitalizations for Endocarditis and Associated Health Care Costs Among Persons with Diagnosed Drug Dependence — north Carolina, 2010–2015. MMWR Morb Mortal Wkly Rep. 2017;66(22):569–573.
   PubMed Web of Science ®Google Scholar
• Martin CA, Burgess DR, and Wallace KL, et al. 1026. trends in infective endocarditis during the substance use disorder epidemic at an academic medical center. In: Open Forum Infectious Diseases. USA: Oxford University Press; 2018. p. S306.
   Google Scholar
• Wright A, Otome O, Harvey C, et al. The current epidemiology of injecting drug use-associated infective endocarditis in Victoria, Australia in the midst of increasing crystal methamphetamine use. Heart Lung Circ. 2018;27(4):484–488.
   PubMed Web of Science ®Google Scholar
• Dayer MJ, Jones S, Prendergast B, et al. Incidence of infective endocarditis in England, 2000-13: a secular trend, interrupted time-series analysis. Lancet. 2015 Mar 28; 385(9974):1219–1228.
   PubMed Web of Science ®Google Scholar
• Parikh MP, Octaria R, Kainer MA. Methicillin-resistant staphylococcus aureus bloodstream infections and injection drug use, Tennessee, USA, 2015-2017. Emerg Infect Dis. 2020;26(3):446–453.
   Web of Science ®Google Scholar
• Klietz M-L, Kaiser HW, and Machens H-G, et al. Infective endocarditis among persons aged 18-64 years with HIV, hepatitis C infection, or opioid use disorder — United States, 2007−20. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America. 2021; 72(10):1767–81. doi:https://doi.org/10.1093/cid/ciaa372.
   PubMed Web of Science ®Google Scholar
• Huang G, Davis KA, Petty SA, et al.Left-sided infective endocarditis in persons who inject drugs.Infection.2020;48(3):375–383;Internet].;():. Available from
   PubMed Web of Science ®Google Scholar
• Pericàs JM, Llopis J, Athan E, et al. Prospective cohort study of infective endocarditis in people who inject drugs. J Am Coll Cardiol. 2021;77(5):544–555.
   PubMed Web of Science ®Google Scholar
• Gray ME, Rogawski Mcquade ET, Scheld WM, et al. Rising rates of injection drug use associated infective endocarditis in Virginia with missed opportunities for addiction treatment referral: a retrospective cohort study. BMC Infect Dis. 2018;18(1):1–9.
   PubMed Web of Science ®Google Scholar
• Rudasill SE, Sanaiha Y, Mardock AL, et al. Clinical outcomes of infective endocarditis in injection drug users. J Am Coll Cardiol. 2019;73(5):559–570.
   PubMed Web of Science ®Google Scholar
• Correa De Sa DD, Tleyjeh IM, Anavekar NS, et al. Epidemiological trends of infective endocarditis: a population-based study in Olmsted County, Minnesota. Mayo Clin Proc. 2010;85(5):422–426.Internet].;():. Available from
   PubMed Web of Science ®Google Scholar
• Ruch Y, Mazzucotelli JP, Lefebvre F, et al. impact of setting up an “endocarditis team” on the management of infective endocarditis. Open Forum Infect Dis. 2019;6(9):1–7.
   Web of Science ®Google Scholar
• Kaura A, Byrne J, Fife A, et al. Inception of the ‘endocarditis team’ is associated with improved survival in patients with infective endocarditis who are managed medically: findings from a before-and-after study. Open Heart. 2017;4(2):e000699.
   PubMed Web of Science ®Google Scholar
• Thakarar K, Rokas KE, Lucas FL, et al. Mortality, morbidity, and cardiac surgery in injection drug use (IDU)-associated versus non-IDU infective endocarditis: the need to expand substance use disorder treatment and harm reduction services. PLoS One. 2019;14(11):e0225460.
   PubMed Web of Science ®Google Scholar
• Damlin A, Westling K. Patients with infective endocarditis and history of injection drug use in a Swedish referral hospital during 10 years. BMC Infect Dis. 2021;21(1):1–9.
   PubMed Web of Science ®Google Scholar
• Leahey PA, LaSalvia MT, and Rosenthal ES, et al. High morbidity and mortality among patients with sentinel admission for injection drug use-related infective endocarditis. In: Open forum infectious diseases. USA: Oxford University Press US; 2019. p. ofz089.
   Google Scholar
• Straw S, Baig MW, Gillott R, et al. Long-term outcomes are poor in intravenous drug users following infective endocarditis, even after surgery. Clin Infect Dis. 2020;71(3):564–571.
   PubMed Web of Science ®Google Scholar
• Suzuki J, Johnson JA, Montgomery MW, et al. Long-term outcomes of injection drug-related infective endocarditis among people who inject drugs. J Addict Med. 2020;14(4):282–286.
   PubMed Web of Science ®Google Scholar
• Halavaara M, Martelius T, and Anttila V-J, et al. Three separate clinical entities of infective endocarditis—a population-based study from Southern Finland 2013–2017. In: Open forum infectious diseases. USA: Oxford University Press US; 2020. p. ofaa334.
   Google Scholar
• Mosseler K, Materniak S, Brothers TD, et al. Epidemiology, microbiology, and clinical outcomes among patients with intravenous drug use-associated infective endocarditis in New Brunswick. CJC Open. 2020;2(5):379–385.
   PubMedGoogle Scholar
• Meisner JA, Anesi J, Chen X, et al. Changes in infective endocarditis admissions in Pennsylvania during the opioid epidemic. Clin Infect Dis. 2020;71(7):1664–1670.
   PubMed Web of Science ®Google Scholar
• Giannitsioti E, Skiadas I, Antoniadou A, et al. Nosocomial vs. community-acquired infective endocarditis in Greece: changing epidemiological profile and mortality risk. Clin Microbiol Infect. 2007 Aug 1 13(8):763–769.
   PubMed Web of Science ®Google Scholar
• Lomas JM, Martínez-Marcos FJ, Plata A, et al. Healthcare-associated infective endocarditis: an undesirable effect of healthcare universalization. Clin Microbiol Infect. 2010;16(11):1683–1690.
   PubMed Web of Science ®Google Scholar
• Benito N, Miró JM, De Lazzari E, et al. Health care–associated native valve endocarditis: importance of non-nosocomial acquisition. Ann Intern Med. 2009;150(9):586–594.
   PubMed Web of Science ®Google Scholar
• Yang F, Zhang B, Yu J, et al. Epidemiology and the prognosis of healthcare–associated infective endocarditis in China: the significance of non-nosocomial acquisition. Emerg Microbes Infect. 2015;4(1):1–6.
   Web of Science ®Google Scholar
• Sanghavi DK, Titus A, Caulfield TR, et al. Endotheliitis, endothelin, and endothelin receptor blockers in COVID-19. Med Hypotheses. 2021;150:110564.
   PubMed Web of Science ®Google Scholar
• Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417–1418.
   PubMed Web of Science ®Google Scholar
• Khanduri A, Anand U, Doss M, et al. Severe acute mitral valve regurgitation in a COVID-19-infected patient. BMJ Case Reports CP. 2021;14(1):e239782.
   PubMedGoogle Scholar
• Toth E, Dancy L, Amin-Youssef G, et al. Collateral implications of the COVID-19 pandemic: belated presentation of infective endocarditis in a young patient. Eur Heart J. 2020;41(45):4365.
   PubMed Web of Science ®Google Scholar
• Hayes DE, Rhee DW, Hisamoto K, et al. Two cases of acute endocarditis misdiagnosed as COVID‐19 infection. Echocardiography. 2021;38(5):798–804.
   PubMed Web of Science ®Google Scholar
• Schizas N, Michailidis T, Samiotis I, et al. Delayed diagnosis and treatment of a critically ill patient with infective endocarditis due to a false-positive molecular diagnostic test for SARS-CoV-2. Am J Case Rep. 2020;21: e925931–1.
   PubMed Web of Science ®Google Scholar
• Skulstad H, Cosyns B, and Popescu BA, et al. COVID-19 pandemic and cardiac imaging: EACVI recommendations on precautions, indications, prioritization, and protection for patients and healthcare personnel. Eur Heart J - Cardiovascular Imaging. 2020;21(6):592–598.
   PubMed Web of Science ®Google Scholar
• Cosyns B, Motoc A, and Arregle F, et al. A plea not to forget infective endocarditis in COVID-19 era. J Am Coll Cardiol Img. 2020;13(11):2470–2471.
   Web of Science ®Google Scholar
• Van Camp G, De Beenhouwer H, Beles M, et al. Disturbing effect of lockdown for COVID-19 on the incidence of infective endocarditis: a word of caution. Clin Res Cardiol. 2020;109(12):1573–1576.
   PubMed Web of Science ®Google Scholar
• Ramos-Martinez A, Fernández-Cruz A, and Dominguez F, et al. Hospital-acquired infective endocarditis during Covid-19 pandemic. Infect Prev Prac. 2020;2(3):100080.
   PubMedGoogle Scholar
• Havers-Borgersen E, Fosbøl EL, Butt JH, et al. Incidence of infective endocarditis during the coronavirus disease 2019 pandemic: a nationwide study. IJC Hear Vasc. 2020;31:100675.
   PubMed Web of Science ®Google Scholar
• Cabral M, Fernandes S, and Santos LG, et al. An outbreak of infective endocarditis during the COVID-19 pandemic?-an observational retrospective single centre study. Eur Hear JAcute Cardiovasc Care. 2021;10(Supplement_1):zuab020–184.
   Google Scholar
• Escolà-Vergè L, Cuervo G, de Alarcón A, et al. Impact of the COVID-19 pandemic on the diagnosis, management and prognosis of infective endocarditis. Clin Microbiol Infect. 2021;27(4):660–664.
   PubMed Web of Science ®Google Scholar
• Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015;132(15):1435–1486.
   PubMed Web of Science ®Google Scholar
• Durack DT, Lukes AS, Bright DK. Duke endocarditis service. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Am J Med. 1994 Mar 1; 96(3):200–209.
   PubMed Web of Science ®Google Scholar
• Vilardell P, Moral S, Bosch D, et al. 3328 Relationship between streptococcal infective endocarditis and pre-neoplastic colorectal lesions. Eur Heart J. 2019;40(Supplement_1):ehz745–0080.
   Google Scholar
• Mahmood M, Kendi AT, Ajmal S, et al. Meta-analysis of 18F-FDG PET/CT in the diagnosis of infective endocarditis. J Nucl Cardiol. 2019;26(3):922–935.
   PubMed Web of Science ®Google Scholar
• Botelho-Nevers E, Thuny F, Casalta JP, et al. Dramatic reduction in infective endocarditis–related mortality with a management-based approach. Arch Intern Med. 2009;169(14):1290–1298.
   PubMedGoogle Scholar
• Chirillo F, Scotton P, Rocco F, et al. Impact of a multidisciplinary management strategy on the outcome of patients with native valve infective endocarditis. Am J Cardiol. 2013;112(8):1171–1176.
   PubMed Web of Science ®Google Scholar
• Habib G, Lancellotti P, Antunes MJ, et al. ESC guidelines for the management of infective endocarditis: the task force for the management of infective endocarditis of the European Society of Cardiology (ESC) endorsed by: european Association for Cardio-Thoracic Surgery (EACTS), the European A. Eur Heart J. 2015;36(44):3075–3128.
   PubMed Web of Science ®Google Scholar
• Nishimura RA, Otto CM, Bonow RO, et al. AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol. 2017;70(2):252–289.
   PubMed Web of Science ®Google Scholar
• Weimer MB, Falker CG, Seval N, et al. the need for multidisciplinary hospital teams for injection drug use-related infective endocarditis. J Addict Med. 2021;Publish Ahead of Print. https://doi.org/10.1097/ADM.0000000000000916.
   Google Scholar
• Pandey M, Batzloff MR, Good MF. Vaccination against rheumatic heart disease: a review of current research strategies and challenges. Curr Infect Dis Rep. 2012;14(4):381–390.
   PubMed Web of Science ®Google Scholar
• Skolnick P. The opioid epidemic: crisis and solutions. Annu Rev Pharmacol Toxicol. 2018;58(1):143–159.
   PubMed Web of Science ®Google Scholar